Nabla Bio

Cambridge, United States

Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.

$26.0M raised

May 2024

Series A

Top Investors

National Science FoundationY CombinatorKhosla VenturesRadical VenturesPillar VC

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Nabla Bio raised?

Nabla Bio has raised $26.0M in total funding. The most recent round was Series A. The last funding was announced in May 2024.

Who are Nabla Bio's investors?

Nabla Bio's investors include National Science Foundation, Y Combinator, Khosla Ventures, Radical Ventures, Pillar VC.

Where is Nabla Bio headquartered?

Nabla Bio is headquartered in Cambridge, United States.

What does Nabla Bio do?

Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.

What stage is Nabla Bio at?

Nabla Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 14, 2024.

MLA

"Nabla Bio — Funding & Investors." VCBacked, May 14, 2024, https://www.vcbacked.co/company/nabla-bio. Accessed June 4, 2026.

APA

VCBacked. (2024). Nabla Bio — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/nabla-bio

Wikipedia (cite web)

{{cite web |title=Nabla Bio — Funding & Investors |url=https://www.vcbacked.co/company/nabla-bio |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 14, 2024.